2019 年南非孕妇产前 HIV 哨点调查中按 HIV 治疗状况划分的梅毒筛查覆盖率和阳性率。
Syphilis screening coverage and positivity by HIV treatment status among South African pregnant women enrolled in the 2019 antenatal HIV sentinel survey.
机构信息
Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa.
School of Public Health, University of the Witwatersrand, 1 Modderfontein Road, Sandringham, Johannesburg, South Africa.
出版信息
Sci Rep. 2023 Apr 1;13(1):5322. doi: 10.1038/s41598-023-32456-0.
We describe coverage of maternal syphilis screening, syphilis positivity, coverage of treatment and their association with maternal HIV infection and antiretroviral treatment (ART) status among pregnant women attending South African antenatal clinics. The 2019 antenatal care sentinel survey was a cross-sectional survey conducted from 1 October to 15 November 2019 at 1589 sentinel sites in all nine provinces of the country and aimed to enrol 36,000 pregnant women ages 15-49 years regardless of HIV, ART or syphilis status. Data collection procedures included obtaining written informed consent, a brief interview, medical record review and blood specimen collection. Completed data collection forms and specimens were sent to designated regional laboratories for data capture and HIV serology testing. Data analysis determined four outcomes i) syphilis screening coverage ii) syphilis positivity iii) coverage of any treatment and iv) with Benzathine penicillin G (BPG). Multivariable logistic regression models with or without interaction between HIV infection and ART status with province were used to determine factors associated with syphilis positivity. Of the 41 598 women enrolled, 35 900 were included in the analysis for syphilis screening coverage. The weighted syphilis screening coverage was 96.4% [95% Confidence Interval (CI) 95.9-96.7%] nationally and was lowest among HIV positive women not on ART at 93.5% (95% CI 92.2-94.5%). Syphilis positivity was 2.6% (95% CI 2.4-2.9%) nationally. Among those who were syphilis positive, 91.9% (95% CI 89.8-93.7%) had documentation of syphilis treatment status, of whom 92.0% (95% CI 89.8-93.9%) were treated, with the majority treated with one or more doses of BPG [92.2% (95% CI 89.8-94.3%)]. HIV-positive women, not on ART [adjusted odd ratio (aOR) 2.24 (95% 1.71-2.93)] and those on ART [aOR 2.25 (95% CI 1.91-2.64)] were more likely to be syphilis positive compared to those who were HIV negative. The national syphilis screening coverage met the global screening target of 95%. Syphilis positivity was higher among HIV positive women compared to negative women. Introduction of rapid syphilis testing and ensuring a universal supply of appropriate treatment for syphilis will reduce the likelihood of mother-to-child transmission of syphilis.
我们描述了南非产前诊所中孕妇梅毒筛查、梅毒阳性、治疗覆盖率及其与艾滋病毒感染和抗逆转录病毒治疗 (ART) 状况的关联。2019 年的产前护理哨点调查是一项横断面调查,于 2019 年 10 月 1 日至 11 月 15 日在该国所有 9 个省份的 1589 个哨点进行,旨在招募 36000 名 15-49 岁的孕妇,无论其艾滋病毒、ART 或梅毒状况如何。数据收集程序包括获得书面知情同意、简短访谈、病历审查和血液样本采集。填写完整的数据收集表和标本被送到指定的区域实验室进行数据捕获和 HIV 血清学检测。数据分析确定了四个结果:i) 梅毒筛查覆盖率,ii) 梅毒阳性率,iii) 任何治疗的覆盖率,iv) 苄星青霉素 G (BPG) 的覆盖率。使用带有或不带有 HIV 感染和 ART 状态与省份之间相互作用的多变量逻辑回归模型,确定与梅毒阳性相关的因素。在纳入的 41598 名妇女中,有 35900 名妇女被纳入梅毒筛查覆盖率分析。全国梅毒筛查覆盖率为 96.4%[95%置信区间 (CI) 95.9-96.7%],未接受 ART 治疗的 HIV 阳性妇女的覆盖率最低,为 93.5%(95%CI 92.2-94.5%)。全国梅毒阳性率为 2.6%(95%CI 2.4-2.9%)。在梅毒阳性的人群中,91.9%(95%CI 89.8-93.7%)有梅毒治疗状况的记录,其中 92.0%(95%CI 89.8-93.9%)接受了治疗,大多数人接受了一剂或多剂 BPG[92.2%(95%CI 89.8-94.3%)]。与 HIV 阴性的妇女相比,未接受 ART 治疗的 HIV 阳性妇女[aOR 2.24(95%置信区间 1.71-2.93)]和接受 ART 治疗的妇女[aOR 2.25(95%置信区间 1.91-2.64)]更有可能梅毒阳性。全国梅毒筛查覆盖率达到了全球 95%的筛查目标。与 HIV 阴性的妇女相比,HIV 阳性的妇女梅毒阳性率更高。引入快速梅毒检测并确保普遍供应适当的梅毒治疗将降低梅毒母婴传播的可能性。